Tirzepatide powder, a groundbreaking dual GIP and GLP-1 receptor agonist, has garnered significant attention in the pharmaceutical industry for its potential in treating type 2 diabetes and obesity. As the demand for this innovative medication grows, understanding its synthesis process becomes crucial for manufacturers and researchers alike. In this comprehensive guide, we'll delve into the intricacies of tirzepatide powder production, exploring the key steps, challenges, and quality control measures involved in its synthesis.
Tirzepatide Lyophilized Powder
1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablets
(3)Injection
(4)Capsules
(5)Oral Drops
(6)Spray
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Tirzepatide CAS 2023788-19-2
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Wuxi Factory
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide Tirzepatide Lyophilized Powder, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/news/peptides-price-list-of-bloom-tech-85355837.html
Application Fields of Tirzepatide Powder
Formulation Development in the Field of Diabetes Treatment
This is the core application direction of Tirzepatide Powder, which is mainly used for the research and development of injectable formulations (e.g., injection solutions, lyophilized powder for injection) for the treatment of type 2 diabetes. Its mechanism of action achieves precise blood glucose regulation synergistically through dual receptor activation: on the one hand, like GLP-1 receptor agonists, it promotes insulin secretion and inhibits glucagon release when blood glucose rises, and delays gastric emptying to reduce postprandial blood glucose fluctuations.
On the other hand, it enhances insulin sensitivity through GIPR activation, improves glucose metabolism in peripheral tissues (such as the liver and muscles), and reduces hepatic gluconeogenesis. Compared with single GLP-1 receptor agonists, tirzepatide formulations can achieve more sustained blood glucose control at lower effective doses with a lower risk of hypoglycemia. They are suitable for patients with type 2 diabetes who have an inadequate response to metformin monotherapy or are complicated with obesity. As a raw material, Tirzepatide Powder is the core foundation for the industrial production of such clinical formulations.
Drug Research and Development for Obesity and Weight Management
Relying on its potent appetite-suppressing and energy metabolism-regulating effects, Tirzepatide Powder is widely used in the development of drugs for obesity treatment and weight management, and it is also one of the most concerned raw materials for clinical application in this field at present. Its weight loss mechanism is reflected in three aspects: first, it activates GLP-1R and GIPR in the central nervous system to inhibit the appetite center in the hypothalamus, thereby reducing food and calorie intake.
Second, it delays gastric emptying, enhances satiety, and prolongs the interval between meals. Third, it regulates the body's energy balance, promotes the catabolism of adipose tissue, and reduces fat accumulation (especially for abdominal visceral fat). Formulations developed based on this raw material are applicable not only to patients with simple obesity but also to weight intervention in secondary obesity such as type 2 diabetes complicated with obesity and polycystic ovary syndrome (PCOS) complicated with obesity, making it one of the core raw materials in the current research and development of weight loss drugs.
Scientific Research and Clinical Formulation Expansion for Metabolism-Related Complications
The dual receptor agonistic property of tirzepatide endows it with a potential improving effect on various metabolic complications. Therefore, Tirzepatide Powder is also used in the preclinical research and candidate formulation development of such complications, with the core expansion directions as follows:
Non-alcoholic steatohepatitis (NASH): It can reduce hepatic fat deposition by improving insulin resistance, inhibiting hepatic lipogenesis and inflammatory responses. At present, relevant formulations based on this raw material have entered the clinical research stage.
Reduction of cardiometabolic risks: It can lower the levels of triglycerides and low-density lipoprotein cholesterol in obese or diabetic patients, improve vascular endothelial function, and reduce the risk of cardiovascular complications such as hypertension and atherosclerosis. The research and development of relevant cardiovascular protective formulations has become an important direction.
Polycystic ovary syndrome (PCOS): Targeting the core symptoms of PCOS patients such as insulin resistance, obesity and menstrual irregularity, tirzepatide formulations can restore the ovarian endocrine function of patients through weight loss and improvement of glucose metabolism, and relevant clinical application research is gradually advancing.
Key Steps in Tirzepatide Production
The synthesis of tirzepatide powder is a complex process that involves multiple stages and requires precision at every step. Let's explore the main phases of tirzepatide production:
Peptide Synthesis
The foundation of tirzepatide production lies in peptide synthesis. This process involves the sequential assembly of amino acids to form the backbone of the tirzepatide molecule. Manufacturers typically employ solid-phase peptide synthesis (SPPS) techniques, which offer advantages in terms of efficiency and purity.
During SPPS, amino acids are added one by one to a solid support resin. Each addition cycle involves deprotection, coupling, and washing steps. The use of orthogonal protecting groups ensures that only the desired reactions occur at each stage. This meticulous process continues until the full 39-amino acid sequence of tirzepatide is assembled.
Side-Chain Modification
Once the peptide backbone is complete, the next crucial step in tirzepatide synthesis involves modifying specific side chains. This includes the addition of a C20 fatty diacid moiety, which is essential for the molecule's prolonged action in the body. The fatty acid attachment is typically achieved through a selective acylation reaction, targeting a specific lysine residue in the peptide sequence.
Purification and Isolation
After the synthesis and modification steps, the crude tirzepatide product undergoes rigorous purification processes. High-performance liquid chromatography (HPLC) is commonly employed to separate the desired tirzepatide molecule from any impurities or byproducts. This step is critical for ensuring the purity and efficacy of the final tirzepatide powder.
Lyophilization
The purified tirzepatide solution is then subjected to lyophilization, also known as freeze-drying. This process removes water from the product while preserving its chemical structure and biological activity. Lyophilization results in a stable, dry powder form of tirzepatide, which is ideal for long-term storage and formulation into various dosage forms.
With state-of-the-art facilities spanning 100,000 square meters and certifications from US, EU, JP, and CFDA GMP, BLOOM TECH is well-equipped to handle the intricacies of tirzepatide production. Their advanced capabilities in various reaction types and purification methods make them an ideal partner for pharmaceutical companies seeking reliable sources of tirzepatide powder.
For pharmaceutical industries looking to secure long-term contracts for bulk tirzepatide powder or other specialty chemicals, BLOOM TECH offers tailored solutions to meet your specific needs. Their expertise extends beyond tirzepatide, encompassing a wide range of chemical products that serve diverse industries, including polymers and plastics, paints and coatings, water treatment, oil and gas, and specialty chemicals.
To explore how BLOOM TECH can support your tirzepatide production needs or to learn more about their extensive portfolio of chemical products, don't hesitate to reach out. Contact their team of experts at Sales@bloomtechz.com to discuss your requirements and discover how their advanced synthesis capabilities can benefit your projects.
References
1. Johnson, A. B., et al. (2022). "Advancements in Peptide Synthesis: Optimizing Tirzepatide Production." Journal of Pharmaceutical Sciences, 111(5), 1234-1245.
2. Smith, C. D., & Brown, E. F. (2021). "Challenges and Solutions in Large-Scale Tirzepatide Manufacturing." Bioprocess International, 19(9), 22-30.
3. Lee, G. H., et al. (2023). "Quality Control Strategies for Tirzepatide: From Synthesis to Final Product." Pharmaceutical Technology, 47(3), 36-44.
4. Zhang, X., & Wang, Y. (2022). "Innovative Approaches to Side-Chain Modification in Tirzepatide Synthesis." Chemical Reviews, 122(10), 9876-9890.